8 24
e
al
is
4
5
a
b
b
12 24
b
24 48
ca
.p
er
si
id
e
oc
c
M
F.
P.
ra
p
ae
nt
P.
x
(D ylo
BM st
e
) lla
1
b
b
b
48 72 h
MAPKKK (RAF27)
LRR-RLK
SnRK (CIPK11)
AGC (AGC2-1)
RLCK
group
AGC (NDR5)
LRR-RLK
LRR-RLK (SRF5)
RLCK
MAPKKK (ANP2)
LysM-RLK
group
L-RLK
LysM-RLK
RLCK
I
II
group III
MYB (MYB15)
AP2-EREBP
AP2-EREBP
AP2-EREBP (RAP2.6)
NAC (ANAC019)
AP2-EREBP
NAC (ANAC055)
WRKY (WRKY40)
NAC (ANAC046)
NAC (ANAC062)
C2H2 (ZFP1)
MYB (MYB34, ATR1)
MYB (MYB95)
WRKY (WRKY60)
bZIP (bZIP7)
bHLH (PIF3, PAP3)
AP2-EREBP
group I
C2H2
C2H2 (JAG)
bHLH (bHLH121)
MYB (MYB54)
C3H
MADS (AGL99)
CCAAT-HAP2
HB
group
BPC (BPC1)
II
HB (HAT4, AtHB-2)
ARR-B
bHLH (bHLH060)
HB (HAT3)
GRAS (GAI) group III
HB (HAT1)
bHLH (bHLH058, BEE2)
bHLH (bHLH064)
HCa-RING
E
HCa-RING
Ubox-RING
C2-RING
group I
A3
v-RING
B7
group II
B4
D2-RING
-3
log2
(
0
treatment
control
3
)
group III
Kinases
Trancription Factors
Ubiquitin Ligases